Obesity
News
Can berberine live up to the claim that it’s ‘nature’s Ozempic’?
The National Center for Complementary and Integrative Health issued a warning...
News
Treating obesity: Will new drugs end the crisis?
The drugs offer new hope to millions with obesity complications. But to truly turn the tide on our 42% obesity rate, much more work remains to be...
News
WHO plans to declare common sweetener as possible carcinogen
Aspartame would join the “possibly” carcinogenic group, which includes gasoline engine exhaust and working as a dry cleaner.
Commentary
Tirzepatide: Therapeutic titan or costly cure?
Positioning tirzepatide as the first injectable of choice after oral treatment escalation with metformin and an SGLT2 inhibitor may remain an...
News
In head and neck cancer, better outcomes seen in patients with overweight
Among 445 patients treated with chemoradiation, those with overweight saw improvements in survival and tumor recurrence, compared with patients...
News
Intermittent fasting, cutting calories give same weight loss
“Time-restricted eating is undoubtedly an attractive approach to weight loss in that it does not require the purchase of expensive food products,...
Conference Coverage
Triple-agonist retatrutide hits new weight loss highs
“I have never seen weight loss at this level” after nearly 1 year of treatment.
Conference Coverage
OASIS and PIONEER PLUS support high-dose oral semaglutide
OASIS-1 showed that “oral semaglutide 50 mg may represent an effective option for the treatment of obesity, particularly in patients who prefer...
Conference Coverage
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
Taken together, results from SURMOUNT-1 and SURMOUNT-2 appear to make a good case for a weight-loss indication that will not depend on whether a...
News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.